Global AI-driven Peptide Drug Discovery Platform Market Research Report 2026

AI-driven Peptide Drug Discovery Platform Market

AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.

The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and Schrödinger and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's "14th Five-Year Plan for Bioeconomic Development" policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.

This report delivers a comprehensive overview of the global AI-driven Peptide Drug Discovery Platform market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI-driven Peptide Drug Discovery Platform. The AI-driven Peptide Drug Discovery Platform market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI-driven Peptide Drug Discovery Platform market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI-driven Peptide Drug Discovery Platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI-driven Peptide Drug Discovery Platform Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Design and Generation Platform

1.2.3 Screening and Optimization Platform

1.2.4 Data-driven Platform

1.2.5 Others

1.3 Market by Application

1.3.1 Global AI-driven Peptide Drug Discovery Platform Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Scientific Research

1.3.3 Pharmaceuticals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global AI-driven Peptide Drug Discovery Platform Market Perspective (2021–2032)

2.2 Global AI-driven Peptide Drug Discovery Platform Growth Trends by Region

2.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI-driven Peptide Drug Discovery Platform Historic Market Size by Region (2021–2026)

2.2.3 AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Region (2027–2032)

2.3 AI-driven Peptide Drug Discovery Platform Market Dynamics

2.3.1 AI-driven Peptide Drug Discovery Platform Industry Trends

2.3.2 AI-driven Peptide Drug Discovery Platform Market Drivers

2.3.3 AI-driven Peptide Drug Discovery Platform Market Challenges

2.3.4 AI-driven Peptide Drug Discovery Platform Market Restraints

3.1 Global Top AI-driven Peptide Drug Discovery Platform Players by Revenue

3.1.1 Global Top AI-driven Peptide Drug Discovery Platform Players by Revenue (2021–2026)

3.1.2 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2021–2026)

3.2 Global Top AI-driven Peptide Drug Discovery Platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI-driven Peptide Drug Discovery Platform Revenue

3.4 Global AI-driven Peptide Drug Discovery Platform Market Concentration Ratio

3.4.1 Global AI-driven Peptide Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI-driven Peptide Drug Discovery Platform Revenue in 2025

3.5 Global Key Players of AI-driven Peptide Drug Discovery Platform Head Offices and Areas Served

3.6 Global Key Players of AI-driven Peptide Drug Discovery Platform, Products and Applications

3.7 Global Key Players of AI-driven Peptide Drug Discovery Platform, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4.1 Global AI-driven Peptide Drug Discovery Platform Historic Market Size by Type (2021–2026)

4.2 Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Type (2027–2032)

5.1 Global AI-driven Peptide Drug Discovery Platform Historic Market Size by Application (2021–2026)

5.2 Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Application (2027–2032)

6.1 North America AI-driven Peptide Drug Discovery Platform Market Size (2021–2032)

6.2 North America AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021–2026)

6.4 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7.1 Europe AI-driven Peptide Drug Discovery Platform Market Size (2021–2032)

7.2 Europe AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021–2026)

7.4 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size (2021–2032)

8.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region (2021–2026)

8.4 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America AI-driven Peptide Drug Discovery Platform Market Size (2021–2032)

9.2 Latin America AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021–2026)

9.4 Latin America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size (2021–2032)

10.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021–2026)

10.4 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 Peptilogics

11.1.1 Peptilogics Company Details

11.1.2 Peptilogics Business Overview

11.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Introduction

11.1.4 Peptilogics Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.1.5 Peptilogics Recent Development

11.2 Pepticom Ltd

11.2.1 Pepticom Ltd Company Details

11.2.2 Pepticom Ltd Business Overview

11.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Introduction

11.2.4 Pepticom Ltd Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.2.5 Pepticom Ltd Recent Development

11.3 Menten AI

11.3.1 Menten AI Company Details

11.3.2 Menten AI Business Overview

11.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Introduction

11.3.4 Menten AI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.3.5 Menten AI Recent Development

11.4 GUBRA

11.4.1 GUBRA Company Details

11.4.2 GUBRA Business Overview

11.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Introduction

11.4.4 GUBRA Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.4.5 GUBRA Recent Development

11.5 Creative Peptides

11.5.1 Creative Peptides Company Details

11.5.2 Creative Peptides Business Overview

11.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Introduction

11.5.4 Creative Peptides Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.5.5 Creative Peptides Recent Development

11.6 Exscalate

11.6.1 Exscalate Company Details

11.6.2 Exscalate Business Overview

11.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Introduction

11.6.4 Exscalate Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.6.5 Exscalate Recent Development

11.7 Generate Biomedicines

11.7.1 Generate Biomedicines Company Details

11.7.2 Generate Biomedicines Business Overview

11.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Introduction

11.7.4 Generate Biomedicines Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.7.5 Generate Biomedicines Recent Development

11.8 Receptor.AI

11.8.1 Receptor.AI Company Details

11.8.2 Receptor.AI Business Overview

11.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Introduction

11.8.4 Receptor.AI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.8.5 Receptor.AI Recent Development

11.9 Insilico Medicine

11.9.1 Insilico Medicine Company Details

11.9.2 Insilico Medicine Business Overview

11.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Introduction

11.9.4 Insilico Medicine Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.9.5 Insilico Medicine Recent Development

11.10 Schrödinger

11.10.1 Schrödinger Company Details

11.10.2 Schrödinger Business Overview

11.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Introduction

11.10.4 Schrödinger Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.10.5 Schrödinger Recent Development

11.11 BenevolentAI

11.11.1 BenevolentAI Company Details

11.11.2 BenevolentAI Business Overview

11.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Introduction

11.11.4 BenevolentAI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.11.5 BenevolentAI Recent Development

11.12 Evotec

11.12.1 Evotec Company Details

11.12.2 Evotec Business Overview

11.12.3 Evotec AI-driven Peptide Drug Discovery Platform Introduction

11.12.4 Evotec Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.12.5 Evotec Recent Development

11.13 PeptiFinder

11.13.1 PeptiFinder Company Details

11.13.2 PeptiFinder Business Overview

11.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Introduction

11.13.4 PeptiFinder Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.13.5 PeptiFinder Recent Development

11.14 Xtalpi

11.14.1 Xtalpi Company Details

11.14.2 Xtalpi Business Overview

11.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Introduction

11.14.4 Xtalpi Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.14.5 Xtalpi Recent Development

11.15 Sun Novo

11.15.1 Sun Novo Company Details

11.15.2 Sun Novo Business Overview

11.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Introduction

11.15.4 Sun Novo Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.15.5 Sun Novo Recent Development

11.16 Zonsen Peplib Biotech

11.16.1 Zonsen Peplib Biotech Company Details

11.16.2 Zonsen Peplib Biotech Business Overview

11.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Introduction

11.16.4 Zonsen Peplib Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.16.5 Zonsen Peplib Biotech Recent Development

11.17 Tide Tron Biotech

11.17.1 Tide Tron Biotech Company Details

11.17.2 Tide Tron Biotech Business Overview

11.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Introduction

11.17.4 Tide Tron Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

11.17.5 Tide Tron Biotech Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

 Table 2. Key Players of Design and Generation Platform

 Table 3. Key Players of Screening and Optimization Platform

 Table 4. Key Players of Data-driven Platform

 Table 5. Key Players of Others

 Table 6. Global AI-driven Peptide Drug Discovery Platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

 Table 7. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 8. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (US$ Million), 2021–2026

 Table 9. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2021–2026)

 Table 10. Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Region (US$ Million), 2027–2032

 Table 11. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2027–2032)

 Table 12. AI-driven Peptide Drug Discovery Platform Market Trends

 Table 13. AI-driven Peptide Drug Discovery Platform Market Drivers

 Table 14. AI-driven Peptide Drug Discovery Platform Market Challenges

 Table 15. AI-driven Peptide Drug Discovery Platform Market Restraints

 Table 16. Global AI-driven Peptide Drug Discovery Platform Revenue by Players (US$ Million), 2021–2026

 Table 17. Global AI-driven Peptide Drug Discovery Platform Market Share by Players (2021–2026)

 Table 18. Global Top AI-driven Peptide Drug Discovery Platform Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI-driven Peptide Drug Discovery Platform Revenue, 2025

 Table 19. Ranking of Global Top AI-driven Peptide Drug Discovery Platform Companies by Revenue (US$ Million) in 2025

 Table 20. Global 5 Largest Players Market Share by AI-driven Peptide Drug Discovery Platform Revenue (CR5 and HHI), 2021–2026

 Table 21. Global Key Players of AI-driven Peptide Drug Discovery Platform, Headquarters and Area Served

 Table 22. Global Key Players of AI-driven Peptide Drug Discovery Platform, Products and Applications

 Table 23. Global Key Players of AI-driven Peptide Drug Discovery Platform, Date of General Availability (GA)

 Table 24. Mergers and Acquisitions, Expansion Plans

 Table 25. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (US$ Million), 2021–2026

 Table 26. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021–2026)

 Table 27. Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Type (US$ Million), 2027–2032

 Table 28. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2027–2032)

 Table 29. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (US$ Million), 2021–2026

 Table 30. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021–2026)

 Table 31. Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Application (US$ Million), 2027–2032

 Table 32. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2027–2032)

 Table 33. North America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 34. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2021–2026

 Table 35. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2027–2032

 Table 36. Europe AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 37. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2021–2026

 Table 38. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2027–2032

 Table 39. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 40. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region (US$ Million), 2021–2026

 Table 41. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region (US$ Million), 2027–2032

 Table 42. Latin America AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 43. Latin America AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2021–2026

 Table 44. Latin America AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2027–2032

 Table 45. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 46. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2021–2026

 Table 47. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (US$ Million), 2027–2032

 Table 48. Peptilogics Company Details

 Table 49. Peptilogics Business Overview

 Table 50. Peptilogics AI-driven Peptide Drug Discovery Platform Product

 Table 51. Peptilogics Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 52. Peptilogics Recent Development

 Table 53. Pepticom Ltd Company Details

 Table 54. Pepticom Ltd Business Overview

 Table 55. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product

 Table 56. Pepticom Ltd Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 57. Pepticom Ltd Recent Development

 Table 58. Menten AI Company Details

 Table 59. Menten AI Business Overview

 Table 60. Menten AI AI-driven Peptide Drug Discovery Platform Product

 Table 61. Menten AI Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 62. Menten AI Recent Development

 Table 63. GUBRA Company Details

 Table 64. GUBRA Business Overview

 Table 65. GUBRA AI-driven Peptide Drug Discovery Platform Product

 Table 66. GUBRA Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 67. GUBRA Recent Development

 Table 68. Creative Peptides Company Details

 Table 69. Creative Peptides Business Overview

 Table 70. Creative Peptides AI-driven Peptide Drug Discovery Platform Product

 Table 71. Creative Peptides Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 72. Creative Peptides Recent Development

 Table 73. Exscalate Company Details

 Table 74. Exscalate Business Overview

 Table 75. Exscalate AI-driven Peptide Drug Discovery Platform Product

 Table 76. Exscalate Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 77. Exscalate Recent Development

 Table 78. Generate Biomedicines Company Details

 Table 79. Generate Biomedicines Business Overview

 Table 80. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product

 Table 81. Generate Biomedicines Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 82. Generate Biomedicines Recent Development

 Table 83. Receptor.AI Company Details

 Table 84. Receptor.AI Business Overview

 Table 85. Receptor.AI AI-driven Peptide Drug Discovery Platform Product

 Table 86. Receptor.AI Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 87. Receptor.AI Recent Development

 Table 88. Insilico Medicine Company Details

 Table 89. Insilico Medicine Business Overview

 Table 90. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product

 Table 91. Insilico Medicine Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 92. Insilico Medicine Recent Development

 Table 93. Schrödinger Company Details

 Table 94. Schrödinger Business Overview

 Table 95. Schrödinger AI-driven Peptide Drug Discovery Platform Product

 Table 96. Schrödinger Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 97. Schrödinger Recent Development

 Table 98. BenevolentAI Company Details

 Table 99. BenevolentAI Business Overview

 Table 100. BenevolentAI AI-driven Peptide Drug Discovery Platform Product

 Table 101. BenevolentAI Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 102. BenevolentAI Recent Development

 Table 103. Evotec Company Details

 Table 104. Evotec Business Overview

 Table 105. Evotec AI-driven Peptide Drug Discovery Platform Product

 Table 106. Evotec Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 107. Evotec Recent Development

 Table 108. PeptiFinder Company Details

 Table 109. PeptiFinder Business Overview

 Table 110. PeptiFinder AI-driven Peptide Drug Discovery Platform Product

 Table 111. PeptiFinder Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 112. PeptiFinder Recent Development

 Table 113. Xtalpi Company Details

 Table 114. Xtalpi Business Overview

 Table 115. Xtalpi AI-driven Peptide Drug Discovery Platform Product

 Table 116. Xtalpi Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 117. Xtalpi Recent Development

 Table 118. Sun Novo Company Details

 Table 119. Sun Novo Business Overview

 Table 120. Sun Novo AI-driven Peptide Drug Discovery Platform Product

 Table 121. Sun Novo Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 122. Sun Novo Recent Development

 Table 123. Zonsen Peplib Biotech Company Details

 Table 124. Zonsen Peplib Biotech Business Overview

 Table 125. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product

 Table 126. Zonsen Peplib Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 127. Zonsen Peplib Biotech Recent Development

 Table 128. Tide Tron Biotech Company Details

 Table 129. Tide Tron Biotech Business Overview

 Table 130. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product

 Table 131. Tide Tron Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (US$ Million), 2021–2026

 Table 132. Tide Tron Biotech Recent Development

 Table 133. Research Programs/Design for This Report

 Table 134. Key Data Information from Secondary Sources

 Table 135. Key Data Information from Primary Sources

 Table 136. Authors List of This Report

List of Figures

 Figure 1. AI-driven Peptide Drug Discovery Platform Picture

 Figure 2. Global AI-driven Peptide Drug Discovery Platform Market Size Comparison by Type (US$ Million), 2021–2032

 Figure 3. Global AI-driven Peptide Drug Discovery Platform Market Share by Type: 2025 vs 2032

 Figure 4. Design and Generation Platform Features

 Figure 5. Screening and Optimization Platform Features

 Figure 6. Data-driven Platform Features

 Figure 7. Others Features

 Figure 8. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (US$ Million), 2021–2032

 Figure 9. Global AI-driven Peptide Drug Discovery Platform Market Share by Application: 2025 vs 2032

 Figure 10. Scientific Research Case Studies

 Figure 11. Pharmaceuticals Case Studies

 Figure 12. AI-driven Peptide Drug Discovery Platform Report Years Considered

 Figure 13. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million), Year-over-Year: 2021–2032

 Figure 14. Global AI-driven Peptide Drug Discovery Platform Market Size, (US$ Million), 2021 vs 2025 vs 2032

 Figure 15. Global AI-driven Peptide Drug Discovery Platform Market Share by Region: 2025 vs 2032

 Figure 16. Global AI-driven Peptide Drug Discovery Platform Market Share by Players in 2025

 Figure 17. Global AI-driven Peptide Drug Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 18. The Top 10 and 5 Players Market Share by AI-driven Peptide Drug Discovery Platform Revenue in 2025

 Figure 19. North America AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 20. North America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021–2032)

 Figure 21. United States AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 22. Canada AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 23. Europe AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 24. Europe AI-driven Peptide Drug Discovery Platform Market Share by Country (2021–2032)

 Figure 25. Germany AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 26. France AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 27. U.K. AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 28. Italy AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 29. Russia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 30. Ireland AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 31. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 32. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Share by Region (2021–2032)

 Figure 33. China AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 34. Japan AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 35. South Korea AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 36. Southeast Asia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 37. India AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 38. Australia & New Zealand AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 39. Latin America AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 40. Latin America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021–2032)

 Figure 41. Mexico AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 42. Brazil AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 43. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 44. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Share by Country (2021–2032)

 Figure 45. Israel AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 46. Saudi Arabia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 47. UAE AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (US$ Million), 2021–2032

 Figure 48. Peptilogics Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 49. Pepticom Ltd Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 50. Menten AI Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 51. GUBRA Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 52. Creative Peptides Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 53. Exscalate Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 54. Generate Biomedicines Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 55. Receptor.AI Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 56. Insilico Medicine Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 57. Schrödinger Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 58. BenevolentAI Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 59. Evotec Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 60. PeptiFinder Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 61. Xtalpi Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 62. Sun Novo Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 63. Zonsen Peplib Biotech Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 64. Tide Tron Biotech Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021–2026)

 Figure 65. Bottom-up and Top-down Approaches for This Report

 Figure 66. Data Triangulation

 Figure 67. Key Executives Interviewed